TrialBMC cancer2023

ctDNA guided adjuvant chemotherapy versus standard of care adjuvant chemotherapy after curative surgery in patients with high risk stage II or stage III colorectal cancer: a multi-centre, prospective, randomised control trial (TRACC Part C).

Susanna Slater et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.